17th Amendment to the Foreign Trade and Payments Ordinance now in force

Fourth Amendment for tightening Investment Screening within one year.

On 1 May 2021, the 17th Amendment to the Foreign Trade and Payments Ordinance entered into force. This is already the fourth change to Germany’s investment screening under foreign trade law within one year, creating additional hurdles for non-EU parties when it comes to investing in German companies. This amendment includes an expansion to the reporting obligation for investments representing a stake of at least 20%, now covering additional industry sectors in next generation technologies, such as artificial intelligence, autonomous driving, semiconductors, optoelectronics, and quantum technology.

Our GSK Update summarizes the key changes under this amendment and illuminates what investors who are domiciled outside of the EU will need to keep in mind in the future when investing in German businesses.

Download GSK Update

Print

Press contact
Christine Ström
+49 30 203907-7763
presse@gsk.de

Back